FOCUS-Drugmakers try evasion, tougher negotiations to fight new U.S. insurer tactic
July 05, 2018 at 07:00 AM EDT
NEW YORK, July 5 (Reuters) - In the escalating battle over U.S. prescription drug prices, major pharmaceutical companies are scrambling to limit the economic damage from a new U.S. insurer tactic that coaxes patients away from expensive drugs.
